These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28974561)

  • 1. Crk Tyrosine Phosphorylation Regulates PDGF-BB-inducible Src Activation and Breast Tumorigenicity and Metastasis.
    Kumar S; Lu B; Davra V; Hornbeck P; Machida K; Birge RB
    Mol Cancer Res; 2018 Jan; 16(1):173-183. PubMed ID: 28974561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
    Sriram G; Jankowski W; Kasikara C; Reichman C; Saleh T; Nguyen KQ; Li J; Hornbeck P; Machida K; Liu T; Li H; Kalodimos CG; Birge RB
    Oncogene; 2015 Aug; 34(32):4260-9. PubMed ID: 25381819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crk adaptor protein-induced phosphorylation of Gab1 on tyrosine 307 via Src is important for organization of focal adhesions and enhanced cell migration.
    Watanabe T; Tsuda M; Makino Y; Konstantinou T; Nishihara H; Majima T; Minami A; Feller SM; Tanaka S
    Cell Res; 2009 May; 19(5):638-50. PubMed ID: 19350053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SH2 domain protein Shep1 regulates the in vivo signaling function of the scaffolding protein Cas.
    Roselli S; Wallez Y; Wang L; Vervoort V; Pasquale EB
    Cell Signal; 2010 Nov; 22(11):1745-52. PubMed ID: 20603213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptor protein Crk induces Src-dependent activation of p38 MAPK in regulation of synovial sarcoma cell proliferation.
    Watanabe T; Tsuda M; Tanaka S; Ohba Y; Kawaguchi H; Majima T; Sawa H; Minami A
    Mol Cancer Res; 2009 Sep; 7(9):1582-92. PubMed ID: 19737974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of c-Src in cells bearing v-Crk and its suppression by Csk.
    Sabe H; Okada M; Nakagawa H; Hanafusa H
    Mol Cell Biol; 1992 Oct; 12(10):4706-13. PubMed ID: 1383688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility.
    Senda Y; Murata-Kamiya N; Hatakeyama M
    Cancer Sci; 2016 Jul; 107(7):972-80. PubMed ID: 27116701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective involvement of p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK activation.
    Kodama H; Fukuda K; Takahashi E; Tahara S; Tomita Y; Ieda M; Kimura K; Owada KM; Vuori K; Ogawa S
    Hypertension; 2003 Jun; 41(6):1372-9. PubMed ID: 12719447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
    Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
    Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial-mesenchymal transition and colorectal cancer aggressiveness.
    Franke FC; Slusarenko BO; Engleitner T; Johannes W; Laschinger M; Rad R; Nitsche U; Janssen KP
    Int J Cancer; 2020 Sep; 147(6):1715-1731. PubMed ID: 32147820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor.
    Koval AP; Blakesley VA; Roberts CT; Zick Y; Leroith D
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):923-32. PubMed ID: 9480911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src.
    Superti-Furga G; Fumagalli S; Koegl M; Courtneidge SA; Draetta G
    EMBO J; 1993 Jul; 12(7):2625-34. PubMed ID: 7687537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
    Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
    Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1.
    Liu W; Yue F; Zheng M; Merlot A; Bae DH; Huang M; Lane D; Jansson P; Lui GY; Richardson V; Sahni S; Kalinowski D; Kovacevic Z; Richardson DR
    Oncotarget; 2015 Apr; 6(11):8851-74. PubMed ID: 25860930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
    Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
    Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crk adaptor proteins regulate CD3ζ chain phosphorylation and TCR/CD3 down-modulation in activated T cells.
    Dong G; Kalifa R; Nath PR; Babichev Y; Gelkop S; Isakov N
    Cell Signal; 2017 Aug; 36():117-126. PubMed ID: 28465009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophilin A Inhibitor Debio-025 Targets Crk, Reduces Metastasis, and Induces Tumor Immunogenicity in Breast Cancer.
    Davra V; Saleh T; Geng K; Kimani S; Mehta D; Kasikara C; Smith B; Colangelo NW; Ciccarelli B; Li H; Azzam EI; Kalodimos CG; Birge RB; Kumar S
    Mol Cancer Res; 2020 Aug; 18(8):1189-1201. PubMed ID: 32321766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins.
    Yokote K; Hellman U; Ekman S; Saito Y; Rönnstrand L; Saito Y; Heldin CH; Mori S
    Oncogene; 1998 Mar; 16(10):1229-39. PubMed ID: 9546424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.